Singapore: President and CEO of Taiwan's TWi Pharmaceuticals, Ms Tina Guilder, has decided to resign from her current roles. Chairman Dr Chih-Ming Chen will become interim president and CEO.

Dr Chen is the founder of TWi and in his role as chairman has historically been the chief architect of TWi's strategy. Taking the CEO role personally, he will focus on operating strategies, making precise product selections, motivating top management and all employees, and integrating the business groups' resources to strengthen the core competencies of TWi.